# argenx vs IDEXX Laboratories: stocks compared

URL: https://funkfolio.com/compare/argx-vs-idxx

> argenx ($59.6B, P/E 32.9) and IDEXX Laboratories ($54.4B, P/E 47.2) compared: size, valuation, margins, debt, cash and price change.

---

## argenx vs IDEXX Laboratories

argenx (ARGX), health care, and IDEXX Laboratories (IDXX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

argenx is worth $59.6B on the stock market and IDEXX Laboratories $54.4B: argenx is valued at 10% more. argenx trades at 32.9 times earnings and IDEXX Laboratories at 47.2; operating margins in their latest fiscal years were 25.4% and 31.6%. Over the past year argenx's share price has moved +3.53% and IDEXX Laboratories's +4.54%.

### Key facts

- **argenx market value:** $59.6B
- **IDEXX Laboratories market value:** $54.4B
- **argenx P/E:** 32.9
- **IDEXX Laboratories P/E:** 47.2
- **argenx revenue:** $4.2B FY to 2025-12-31
- **IDEXX Laboratories revenue:** $4.3B FY to 2025-12-31
- **Superinvestors holding both:** 1

Market values as of 18 Nov 2026, 04:52 UTC.

argenx vs IDEXX Laboratories: every measure side by side

| Measure | argenx | IDEXX Laboratories |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | Belgium | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $59.6B higher | $54.4B lower |
| Revenue | $4.2B lower | $4.3B higher |
| Earnings | $1.3B higher | $1.1B lower |
| Employees | 1,863 lower | 11,000 higher |
| Total assets | $8.7B higher | $3.4B lower |
| Valuation |  |  |
| P/E | 32.9 lower | 47.2 higher |
| P/S | 14.4 higher | 12.6 lower |
| P/B | — | 29.1 |
| Dividend yield | — | 0.00% |
| Profitability |  |  |
| Operating margin | 25.4% lower | 31.6% higher |
| Balance sheet |  |  |
| Net assets | $7.3B higher | $1.6B lower |
| Total liabilities | $1.4B lower | $1.7B higher |
| Total debt | — | $450M |
| Cash on hand | $3.5B higher | $180.1M lower |
| Price change |  |  |
| Today | -0.36% higher | -1.49% lower |
| 1 year | +3.53% lower | +4.54% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: argenx 101.9, IDEXX Laboratories 103.2.

- argenx (ARGX)
- IDEXX Laboratories (IDXX)

argenx and IDEXX Laboratories share prices over one year, rebased to 100: argenx ends at 101.9, IDEXX Laboratories at 103.2.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | ARGX | IDXX |
| --- | --- | --- |
| Nov 28, 2025 | 98.1 | 112.5 |
| Dec 31, 2025 | 90.5 | 101.1 |
| Jan 30, 2026 | 90.4 | 100.2 |
| Feb 27, 2026 | 82.5 | 98.2 |
| Mar 31, 2026 | 78.6 | 84.0 |
| Apr 30, 2026 | 84.1 | 83.8 |
| May 29, 2026 | 89.9 | 84.2 |
| Jun 30, 2026 | 99.8 | 78.7 |
| Jul 31, 2026 | 91.8 | 83.6 |
| Aug 31, 2026 | 111.0 | 83.2 |
| Sep 30, 2026 | 103.2 | 78.1 |
| Oct 30, 2026 | 96.0 | 82.4 |
| Nov 17, 2026 | 101.9 | 103.2 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (1)

- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.2% / 1.6%

#### argenx only (1)

- [Frank Sands](https://funkfolio.com/gurus/frank-sands) 1.0%

#### IDEXX Laboratories only (9)

- [Terry Smith](https://funkfolio.com/gurus/terry-smith) 2.9%
- [Polen Capital team](https://funkfolio.com/gurus/polen-capital) 2.2%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) 1.8%
- [Wallace Weitz](https://funkfolio.com/gurus/wallace-weitz) 1.3%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.2%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": argenx / IDEXX Laboratories). [Who owns ARGX](https://funkfolio.com/stock/ARGX/superinvestors) · [Who owns IDXX](https://funkfolio.com/stock/IDXX/superinvestors)

### More on argenx

- [argenx (ARGX) stock page](https://funkfolio.com/stock/ARGX)
- [argenx market cap](https://funkfolio.com/stock/ARGX/market-cap)
- [argenx revenue](https://funkfolio.com/stock/ARGX/revenue)
- [argenx P/E ratio](https://funkfolio.com/stock/ARGX/pe-ratio)
- [argenx operating margin](https://funkfolio.com/stock/ARGX/operating-margin)
- [argenx total debt](https://funkfolio.com/stock/ARGX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on IDEXX Laboratories

- [IDEXX Laboratories (IDXX) stock page](https://funkfolio.com/stock/IDXX)
- [IDEXX Laboratories market cap](https://funkfolio.com/stock/IDXX/market-cap)
- [IDEXX Laboratories revenue](https://funkfolio.com/stock/IDXX/revenue)
- [IDEXX Laboratories P/E ratio](https://funkfolio.com/stock/IDXX/pe-ratio)
- [IDEXX Laboratories operating margin](https://funkfolio.com/stock/IDXX/operating-margin)
- [IDEXX Laboratories total debt](https://funkfolio.com/stock/IDXX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### argenx against its closest peers

- [argenx vs Edwards Lifesciences](https://funkfolio.com/compare/argx-vs-ew)
- [argenx vs Becton, Dickinson](https://funkfolio.com/compare/argx-vs-bdx)
- [argenx vs Cardinal Health](https://funkfolio.com/compare/argx-vs-cah)
- [argenx vs Boston Scientific](https://funkfolio.com/compare/argx-vs-bsx)

#### IDEXX Laboratories against its closest peers

- [IDEXX Laboratories vs Medline](https://funkfolio.com/compare/idxx-vs-mdln)
- [IDEXX Laboratories vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-idxx)
- [IDEXX Laboratories vs Edwards Lifesciences](https://funkfolio.com/compare/ew-vs-idxx)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, argenx or IDEXX Laboratories?**

By market value, argenx is the larger: $59.6B against $54.4B for IDEXX Laboratories. By revenue in its latest fiscal year, IDEXX Laboratories is the larger: $4.3B against $4.2B for argenx.

**Which has the higher P/E ratio?**

IDEXX Laboratories: 47.2, against 32.9 for argenx. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

IDEXX Laboratories: 31.6%, against 25.4% for argenx. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which superinvestors own both argenx and IDEXX Laboratories?**

In their latest 13F filings, Ron Baron holds both.

### Cite this page

Funkfolio, “argenx vs IDEXX Laboratories”, data as of 18 November 2026. https://funkfolio.com/compare/argx-vs-idxx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
